Guangdong Biolight Meditech Co Ltd Asset Resilience Ratio

Latest as of June 2026: 1.02%

Guangdong Biolight Meditech Co Ltd asset resilience ratio. Guangdong Biolight Meditech Co Ltd (300246) has an Asset Resilience Ratio of 1.02% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Guangdong Biolight Meditech Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥25.14 Million

≈ $3.68 Million USD Cash + Short-term Investments

Total Assets

CN¥2.45 Billion

≈ $359.07 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Guangdong Biolight Meditech Co Ltd (2015–2024)

Asset resilience ratio of Guangdong Biolight Meditech Co Ltd from 2015 to 2024. This chart shows how Guangdong Biolight Meditech Co Ltd's Asset Resilience Ratio has changed over time. Read Guangdong Biolight Meditech Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Guangdong Biolight Meditech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Guangdong Biolight Meditech Co Ltd assets under control.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥25.14 Million	1.02%
Total Liquid Assets	CN¥25.14 Million	1.02%

Asset Resilience Insights

Limited Liquidity: Guangdong Biolight Meditech Co Ltd maintains only 1.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guangdong Biolight Meditech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangdong Biolight Meditech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Applied BioCode TW:6598	Medical Devices	9.75%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Cleo Diagnostics Ltd AU:COV	Medical Devices	94.64%
Radiant Innovation TWO:3373	Medical Devices	0.82%
Impedimed Ltd AU:IPD	Medical Devices	46.15%
Memphasys Ltd AU:MEM	Medical Devices	0.00%

Guangdong Biolight Meditech Co Ltd Asset Resilience Ratio by Year (2015–2024)

Guangdong Biolight Meditech Co Ltd asset resilience ratio by year from 2015 to 2024. The table below shows the annual Asset Resilience Ratio data for Guangdong Biolight Meditech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	10.56%	CN¥263.97 Million ≈ $38.63 Million	CN¥2.50 Billion ≈ $365.66 Million	+7.32pp
2020-12-31	3.25%	CN¥52.20 Million ≈ $7.64 Million	CN¥1.61 Billion ≈ $235.18 Million	+0.13pp
2019-12-31	3.12%	CN¥30.00 Million ≈ $4.39 Million	CN¥961.46 Million ≈ $140.69 Million	+2.25pp
2016-12-31	0.87%	CN¥6.00 Million ≈ $877.99K	CN¥686.57 Million ≈ $100.47 Million	+0.19pp
2015-12-31	0.69%	CN¥4.00 Million ≈ $585.33K	CN¥580.65 Million ≈ $84.97 Million	--

pp = percentage points

About Guangdong Biolight Meditech Co Ltd

SHE:300246 China Medical Devices

Market Cap

$503.27 Million

CN¥3.44 Billion CNY

Market Cap Rank

#11887 Global

#3382 in China

Share Price

CN¥12.99

Change (1 day)

+4.09%

52-Week Range

CN¥7.83 - CN¥21.57

All Time High

CN¥30.12